TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT06818084

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06818084
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06818084. Non-randomized; no masking; primary purpose treatment. Start 2025-04-29 (actual); primary completion 2027-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
Acronym
TRAMPERS
Condition
AORTIC VALVE DISEASES
Condition
Aortic Regurgitation
Intervention (Combination product)
VitaFlow+GDMT
Intervention (Combination product)
J-Valve+GDMT
Lead sponsor
Ruijin Hospital (class: other)

Record details

Record id
cardio:ct-nct06818084
Content hash
2a0818c46ef4b3cf6fd5c50d43601802b548fdc9d643692eebfa162ac35b74e8